Cargando…
siRNA‐based nanotherapeutics as emerging modalities for immune‐mediated diseases: A preliminary review
Immune‐mediated diseases (IMDs) are chronic conditions that have an immune‐mediated etiology. Clinically, these diseases appear to be unrelated, but pathogenic pathways have been shown to connect them. While inflammation is a common occurrence in the body, it may either stimulate a favorable immune...
Autores principales: | Sargazi, Saman, Arshad, Rabia, Ghamari, Reza, Rahdar, Abbas, Bakhshi, Ali, Karkan, Sonia Fathi, Ajalli, Narges, Bilal, Muhammad, Díez‐Pascual, Ana M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543380/ https://www.ncbi.nlm.nih.gov/pubmed/35830711 http://dx.doi.org/10.1002/cbin.11841 |
Ejemplares similares
-
Peptide-siRNA nanotherapeutics in arthritis
por: Pham, Christine T.N., et al.
Publicado: (2015) -
Novel Perspectives towards RNA-Based Nano-Theranostic Approaches for Cancer Management
por: Arshad, Rabia, et al.
Publicado: (2021) -
The emerging potential of siRNA nanotherapeutics in treatment of arthritis
por: Kumari, Anjali, et al.
Publicado: (2023) -
Active Targeted Nanoparticles for Delivery of Poly(ADP-ribose) Polymerase (PARP) Inhibitors: A Preliminary Review
por: Sargazi, Saman, et al.
Publicado: (2021) -
Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment
por: Hattab, Dima, et al.
Publicado: (2021)